Related Experiment Video
Updated: May 1, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Primary prophylaxis of variceal bleeding.
Douglas A Simonetto1, Vijay H Shah1, Patrick S Kamath1
1Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Department of Physiology, Advanced Liver Disease Study Group, Fiterman Center for Digestive Diseases, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.
Primary prevention of variceal bleeding in cirrhosis patients is crucial. Nonselective beta-blockers and endoscopic band ligation are equally effective for high-risk individuals, though optimal strategy remains debated.
Area of Science:
- Hepatology
- Gastroenterology
- Internal Medicine
Background:
- Variceal bleeding is a significant complication in patients with cirrhosis and esophageal varices.
- Primary prophylaxis is recommended for high-risk patients, including those with small varices and advanced liver disease or red wale marks, and those with medium/large varices.
Purpose of the Study:
- To review established recommendations for the primary prevention of esophageal variceal bleeding.
- To discuss recent advances and ongoing controversies in managing high-risk cirrhotic patients.
Main Methods:
- Review of existing clinical guidelines and published literature on primary prophylaxis of variceal bleeding.
- Analysis of comparative effectiveness of nonselective beta-blockers versus endoscopic band ligation.
Main Results:
- Nonselective beta-blockers and endoscopic band ligation are the only recommended therapies for primary prevention.
- Both methods demonstrate equal efficacy in preventing the first variceal bleeding episode.
Conclusions:
- Established recommendations support nonselective beta-blockers and endoscopic band ligation as equally effective primary prevention strategies.
- The choice between these two therapies for high-risk patients with cirrhosis remains a subject of ongoing clinical discussion.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Esophageal Varices-I: Introduction
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

